Clinical fracture incidence in metastatic hormone-sensitive prostate cancer (mhspc) and risk-reduction following addition of zoledronic acid to androgen deprivation therapy (adt) with or without docetaxel (doc): long-term results from 2 phase 3 trials from the stampede platform protocol
JOURNAL OF UROLOGY（2023）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined